Vanadate-induced activation of cytosolic phospholipase A2α in L929 cells: Roles of tyrosine kinase, protein kinase C, and extracellular signal-regulated kinase

Biochemical Pharmacology

Volumn 73, Issue 6, 2007, Pages 854-862

  Taniguchi, Tomoko ^a   Shimizu, Masaya ^a   Nakamura, Hiroyuki ^a   Hirabayashi, Tetsuya ^a   Fujino, Hiromichi ^a   Saito, Takeshi ^b   Murayama, Toshihiko ^a  

^a CHIBA UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

cPLA2 ; ERK1 2; Murine L929 cells; PKC; Src; Vanadate

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ARACHIDONIC ACID; CALCIMYCIN; CALCIUM IONOPHORE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; PYRROPHENONE; UNCLASSIFIED DRUG; VANADATE SODIUM;

ANIMAL CELL; ARTICLE; CELL STRAIN; CELL STRAIN L 929; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONIC ACID; CALCIUM; CELLS, CULTURED; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HYDROGEN PEROXIDE; MICE; PHOSPHOLIPASES A; PROTEIN KINASE C; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; VANADATES;

EID: 33846867507     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.11.026     Document Type: Article

References (45)

1. Huyer G., Liu S., Kelly J., Moffat J., Payette P., Kennedy B., et al. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem 272 (1997) 843-851
2. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol 10 (1998) 248-253
3. Bhattacharyya S., and Tracey A.S. Vanadium (V) complexes in enzyme systems: aqueous chemistry, inhibition and molecular modeling in inhibitor design. J Inorg Biochem 85 (2001) 9-13
4. Scior T., Guevara-Garcia A., Bernard P., Do Q.T., Domeyer D., and Laufer S. Are vanadium compounds drugable? Structures and effects of antidiabetic vanadium compounds. Mini Rev Med Chem 5 (2005) 995-1008
5. Saito S., Frank G.D., Mifune M., Ohba M., Utsunomiya H., Motley E.D., et al. Ligand-independent trans-activation of the platelet-derived growth factor receptor by reactive oxygen species requires protein kinase-δ and c-Src. J Biol Chem 277 (2002) 44695-44700
6. Kim J.T., and Joo C.K. Involvement of cell-cell interactions in the rapid stimulation of Cas tyrosine phosphorylation and Src kinase activity by transforming growth factor-β1. J Biol Chem 277 (2002) 31938-31948
7. Lee Y.J., Cho H.N., Soh J.W., Jhon G.J., Cho C.K., Chung H.Y., et al. Oxidative stress-induced apoptosis is mediated by ERK1/2 phosphorylation. Exp Cell Res 291 (2003) 251-266
8. src activation in human paltelets. J Biol Chem 279 (2004) 1665-1675
9. Huang C., Zhang Z., Ding M., Li J., Ye J., Leonard S.S., et al. Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis. J Biol Chem 275 (2000) 32516-32522
10. Zhang Z., Huang C., Li J., Leonard S.S., Lanciotti R., Butterworth L., et al. Vanadate-induced cell growth regulation and the role of reactive oxygen species. Arch Biochem Biophys 392 (2001) 311-320
11. Yasuda Y., Yoshinaga N., Murayama T., and Nomura Y. Inhibition of hydrogen peroxide-induced apoptosis but not arachidonic acid release in GH3 cells by EGF. Brain Res 850 (1999) 197-206
12. 4 in PC12 cells and GH3 cells. Eur J Pharmacol 417 (2001) 19-25
13. Törnquist K., Dugué B., and Ekokoski E. Protein tyrosine phosphorylation and calcium signaling in thyroid FRTL-5 cells. J Cell Physiol 175 (1998) 211-219
14. 2 activation is via the MKP-1 down-regulation and ERK activation. Cell Signal 12 (2000) 457-461
15. Alcón S., Camello P.J., García L.J., and Pozo M.J. Activation of tyrosine kinase pathway by vanadate in gallbladder smooth muscle. Biochem Pharmacol 59 (2000) 1077-1089
16. 2. J Biol Chem 272 (1997) 16709-16712
17. 2. Biol Pharm Bull 27 (2004) 1168-1173
18. 2 on arachidonic acid release induced by reactive oxygen species. Arch Biochem Biophys 392 (2001) 257-262
19. 2) in hydrogen peroxide-induced arachidonic acid release in murine mesangial cells. J Biol Chem 278 (2003) 24153-24163
20. 2 in activated cells. Cell Signal 17 (2005) 1052-1062
21. 2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol Chem 268 (1993) 11290-11295
22. 2 is necessary for tumor necrosis factor α-induced ceramide generation in L929 cells. J Biol Chem 272 (1997) 17196-17203
23. 2+ ionophores, but not tumor necrosis factor-α. J Pharmacol Sci 96 (2004) 324-332
24. Nakamura H., Hirabayashi T., Shimizu M., and Murayama T. Ceramide-1-phosphate activates cytosolic phospholipase A2α directly and by PKC pathway. Biochem Pharmacol 71 (2006) 850-857
25. Nakamura H., Takashiro Y., Hirabayashi T., Horie S., Koide Y., Nishida A., et al. Effects of synthetic sphingosine-1-phosphate analogs on arachidonic acid metabolism and cell death. Biochem Pharmacol 68 (2004) 2187-2196
26. 2α, pyrrophenone. Biochem J 363 (2002) 727-735
27. Singer A.G., Ghomashchi F., Le Calvez C., Bollinger J., Bezzine S., Rouault M., et al. Interfacial kinetic and binding properties of the complete set of human and mouse Groups I, II, V, X, and XII secreted phospholipase A2. J Biol Chem 277 (2002) 48535-48549
28. Yokota Y., Hanasaki K., Ono T., Nakazato H., Kobayashi T., and Arita H. Suppression of murine endotoxic shock by sPLA2 inhibitor, indoxam, through group IIA sPLA2-independent mechanisms. Biochim Biophys Acta 1438 (1999) 213-222
29. 2α. Eur J Pharmacol 546 (2006) 1-10
30. 2. J Biol Chem 279 (2004) 48692-48701
31. O'Connell M.A., Kelleher D., Liskamp R.M., Hall N., O'Neill L.A.J., and Long A. TNF-mediated cytotoxicity of L929 cells: role of staurosporine in enhancement of cytotoxicity and translocation of protein kinase C isozymes. Cytokine 9 (1997) 83-92
32. Lee J.Y., Hannun Y.A., and Obeid L.M. Functional dichotomy of protein kinase C (PKC) in tumor necrosis factor-α (TNF-α) signal transduction in L929 cells. J Biol Chem 275 (2000) 29290-29298
33. 2 for platelet-derived growth factor signal transduction. Science 270 (1995) 296-299
34. Kim Y.R., Cha H.Y., Lim K., Hwang B.D., Hoe K.L., Namgung U., et al. Activation of epidermal growth factor receptor is responsible for pervanadate-induced phospholipase D activation. Exp Mol Med 35 (2003) 118-124
35. Chien P.S., Mak O.T., and Huang H.J. Induction of COX-2 protein expression by vanadate in A549 human lung carcinoma cell line through EGF receptor and p38 MAPK-mediated pathway. Biochem Biophys Res Commun 339 (2006) 562-568
36. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9 (1995) 484-496
37. Kikkawa U., Matsuzaki H., and Yamamoto T. Protein kinase C δ (PKCδ): activation mechanisms and functions. J Biochem (Tokyo) 132 (2002) 831-839
38. 2-treated cells and its activation by tyrosine kinase in vitro. Proc Natl Acad Sci USA 98 (2001) 6587-6592
39. Rodríguez-Fernández J.L., and Rozengurt E. Bonbesin, bradikinin, vasopressin, and phorbol esters rapidly and transiently activate Src family tyrosine kinases in Swiss 3T3 cells. J Biol Chem 271 (1996) 27895-27901
40. Landgren E., Blume-Jensen P., Courtneidge S.A., and Claesson-Welsh L. Fibroblast growth factor receptor-1 regulation of Src family kinases. Oncogene 10 (1995) 2027-2035
41. Brandt D.T., Goerke A., Heuer M., Gimona M., Leitges M., Kremmer E., et al. Protein kinase Cδ induces Src kinase activity via activation of the protein tyrosine phosphatase PTPα. J Biol Chem 278 (2003) 34073-34078
42. Waldron R.T., and Rozengurt E. Oxidative stress induces protein kinase D activation in intact cells: involvement of Src and dependence of protein kinase C. J Biol Chem 275 (2000) 17114-17121
43. Kim J., Min G., Bae Y.S., and Min D.S. Phospholipase D is involved in oxidative stress-induced migration of vascular smooth muscle cells via tyrosine phosphorylation and protein kinase C. Exp Mol Med 36 (2004) 103-109
44. 2, and phosphatase inhibitors activate endothelial cell ERK1/2 MAP-kinase. Microvasc Res 69 (2005) 36-44
45. 2 regulates the activation of distinct MAPK pathways. Free Radic Biol Med 33 (2002) 1121-1132